ConforMIS is a medical technology company that uses its proprietary iFitÂŽ Image-to-ImplantÂŽ technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patientâs unique anatomy. ConforMIS offers a broad line of customized knee implants designed to restore the natural shape of a patientâs knee. In recent clinical studies, iTotalÂŽ CR, ConforMISâ cruciate-retaining total knee replacement implant and best-selling product, demonstrated superior clinical outcomes, including better function and greater patient satisfaction compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints and other elements of the iFitÂŽ Image-to-ImplantÂŽ technology platform. ConforMIS believes its iFitÂŽ Image-to-ImplantÂŽ technology platform has application to other major joints in the worldwide market for joint replacement products. Source
No articles found.
Cyclacel's founding scientist, Professor Sir David Lane, a globally recognized aut...
Cyclacel's founding scientist, Professor Sir Da...
NextCure is a clinical-stage biopharmaceutical company committed to discovering an...
NextCure is a clinical-stage biopharmaceutical ...
BIOLASE, Inc. is a medical device company and global market leader in the manufact...
BIOLASE, Inc. is a medical device company and g...
OraSure Technologies is empowering the global community to improve health and well...
OraSure Technologies is empowering the global c...
Neuronetics, Inc. is focused on designing, developing, and marketing products that...
Neuronetics, Inc. is focused on designing, deve...
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncol...
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) ...
Inogenâs mission to improve the quality of life of supplemental oxygen users beg...
Inogenâs mission to improve the quality of li...
Join the National Investor Network and get the latest information with your interests in mind.